Livzon Pharmaceutical Group Inc (000513) — Free Cash Flow Generation Index
Livzon Pharmaceutical Group Inc (000513) has a Free Cash Flow Generation Index of 0.87x as of December 2025. Free cash flow of CN¥546.97 Million represents 1% of operating cash flow (CN¥625.70 Million). Read 000513 liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Livzon Pharmaceutical Group Inc Free Cash Flow Generation Index (1999–2025)
Historical FCF Generation Index trend for Livzon Pharmaceutical Group Inc across 27 annual periods. Explore reinvestment intensity of Livzon Pharmaceutical Group Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Livzon Pharmaceutical Group Inc (1999–2025)
Year-by-year Free Cash Flow Generation Index for Livzon Pharmaceutical Group Inc. For the full company profile including market capitalisation, see 000513 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥2.60 Billion | CN¥3.18 Billion | CN¥574.14 Million | ▲ +1.3% |
| 2024 | 0.81x | CN¥2.41 Billion | CN¥2.98 Billion | CN¥570.16 Million | ▲ +8.2% |
| 2023 | 0.75x | CN¥2.43 Billion | CN¥3.25 Billion | CN¥820.45 Million | ▲ +13.1% |
| 2022 | 0.66x | CN¥1.83 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▲ +111.9% |
| 2021 | 0.31x | CN¥593.23 Million | CN¥1.90 Billion | CN¥1.31 Billion | ▼ -55.5% |
| 2020 | 0.70x | CN¥1.51 Billion | CN¥2.16 Billion | CN¥646.98 Million | ▼ -9.6% |
| 2019 | 0.77x | CN¥1.37 Billion | CN¥1.77 Billion | CN¥398.00 Million | ▲ +23.8% |
| 2018 | 0.63x | CN¥793.15 Million | CN¥1.27 Billion | CN¥474.47 Million | ▼ -19.4% |
| 2017 | 0.78x | CN¥1.02 Billion | CN¥1.32 Billion | CN¥294.15 Million | ▲ +9.1% |
| 2016 | 0.71x | CN¥910.76 Million | CN¥1.28 Billion | CN¥368.46 Million | ▲ +46.6% |
| 2015 | 0.49x | CN¥450.65 Million | CN¥927.79 Million | CN¥477.13 Million | ▲ +571.7% |
| 2014 | 0.07x | CN¥51.87 Million | CN¥717.39 Million | CN¥665.52 Million | ▲ +106.6% |
| 2013 | -1.09x | CN¥-480.01 Million | CN¥439.99 Million | CN¥920.00 Million | ▼ -284.9% |
| 2012 | -0.28x | CN¥-168.34 Million | CN¥593.96 Million | CN¥762.30 Million | ▼ -155.9% |
| 2011 | 0.51x | CN¥359.37 Million | CN¥708.20 Million | CN¥348.83 Million | ▲ +8.4% |
| 2010 | 0.47x | CN¥296.34 Million | CN¥633.30 Million | CN¥336.95 Million | ▼ -36.3% |
| 2009 | 0.73x | CN¥363.47 Million | CN¥494.88 Million | CN¥131.41 Million | ▼ -6.0% |
| 2008 | 0.78x | CN¥269.66 Million | CN¥345.18 Million | CN¥75.52 Million | ▲ +23.5% |
| 2007 | 0.63x | CN¥157.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▲ +211.4% |
| 2006 | 0.20x | CN¥46.01 Million | CN¥226.46 Million | CN¥180.45 Million | ▲ +134.2% |
| 2005 | -0.59x | CN¥-95.65 Million | CN¥161.07 Million | CN¥256.72 Million | ▼ -408.0% |
| 2004 | 0.19x | CN¥34.98 Million | CN¥181.46 Million | CN¥146.48 Million | ▼ -70.6% |
| 2003 | 0.65x | CN¥196.45 Million | CN¥300.01 Million | CN¥103.56 Million | ▲ +27.1% |
| 2002 | 0.52x | CN¥110.03 Million | CN¥213.65 Million | CN¥103.62 Million | ▲ +8.5% |
| 2001 | 0.47x | CN¥73.66 Million | CN¥155.15 Million | CN¥81.48 Million | ▲ +179.6% |
| 2000 | -0.60x | CN¥-22.98 Million | CN¥38.52 Million | CN¥61.49 Million | ▼ -185.0% |
| 1999 | 0.70x | CN¥172.78 Million | CN¥246.23 Million | CN¥73.44 Million | — |